ADVERTISEMENT

attend 2000 x 399 (1)

Share

    


In This Section

Home / Attend

Attend

Looking for opportunities for professional growth and resources for process and quality improvement? ACCC offers guidance, best practices, and accredited education resources and events.

ACCC Meetings

State Events

 

Upcoming Webinars

Advances in Cancer Immunotherapy Series: A Focus on Toxicity Management

Tuesday, May 14 from 11 AM-3 PM EST

Join SITC and a panel of experts, via Zoom, for an afternoon of in-depth education on all aspects of toxicity management. FREE for healthcare professionals, students, patients and patient advocates.

Physician Education: 3.75 AMA PRA Category 1™
Pharmacy Education: 3.75 contact hours (0.375 CEUs)
Nursing Education: 3.75 contact hours
Register Now

Advances in Cancer Immunotherapy Series: A Focus on Genitourinary Cancers

Tuesday, June 11 from 11 AM-3 PM EST

Join SITC and a panel of experts, via Zoom, for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for genitourinary cancers. FREE for healthcare professionals, students, patients and patient advocates.

Physician Education: 3.75 AMA PRA Category 1TM
Pharmacy Education: 3.75 contact hours (0.375 CEUs)
Nursing Education: 3.75 contact hours
Register Now

Advances in Cancer Immunotherapy Series: A Focus on Lung Cancer

Tuesday, June 25 from 1-5 PM EST

Join SITC and a panel of experts, via Zoom for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for lung cancer. FREE for healthcare professionals, students, patients and patient advocates.
Register Now

Advances in Cancer Immunotherapy Series: A Focus on Hematologic Malignancies

Wednesday, September 11 from 1-5 PM EST

Join SITC and a panel of experts, via Zoom, for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for hematologic malignancies. FREE for healthcare professionals, students, patients and patient advocates.
Register Now

Advances in Cancer Immunotherapy Series: A Focus on Intratumoral Therapies Vaccines and Cytokines

Wednesday, October 9 from 11 AM-3 PM EST

Join SITC and a panel of experts, via Zoom, for an afternoon of in-depth education on all aspects of intratumoral therapies, vaccines, & cytokines. FREE for healthcare professionals, students, patients and patient advocates.
Register Now

On-Demand Webinars

Expanding Access to Cellular and Bispecific Therapies:
Considerations and Recommendations

March 14, 2024 | 4–5 PM CST

For this webinar, ACCC and SITC have gathered feature experts to review the 3 areas of focus: Education, Coordination, and Facilitation in the Expanding Access to Cellular Therapies Report. A live Question & Answer session for attendees interested in beginning their own program will also be offered.
View Archived Webinar

On-Demand Webinars

  • Addressing disparities in prostate cancer requires the ability to recognize that care inequities exist and to commit to proven efforts to provide equitable care to all patients. This is not an easy undertaking—but an essential one for any healthcare team.

  • This enduring material was recorded from a virtual (live) summit offered by the American Society for Clinical Pathology (ASCP) and the Association of Community Cancer Centers (ACCC) to help members of the cancer care team enhance their coordination of patient care and gain deeper scientific knowledge, skills, and competence in biomarker testing practices, treatment selection, and management of adverse events in patients with advanced NSCLC.

  • Hear considerations for treating patients with CLL during the pandemic, including best options, treatment timing, changes to the usual regimen, and how to prepare for the future.

  • The pandemic has heightened the distress patients with CLL face and taken its toll on providers. Learn strategies and solutions to these challenges and the path forward for providing patient care.

  • Panelists discussed considerations for resuming pre-pandemic level visits and procedures for patients with CLL, AML, and Multiple Myeloma. Hear wins and challenges in providing care in a pandemic.